Emerald Organic Prod
Emerald Organic Products Inc. Announces Corporate Name Change to Healixa, Solidifying a Position at the Tech Table
February 24, 2021 12:59 ET | Emerald Organic Products Inc.
Holbrook, New York, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Emerald Organic Products Inc. (d/b/a Healixa Inc.) (OTC: EMOR) (the “Company”, "EMOR", “Healixa”), a people-first digital organization that...
5e70ba2109b32d0004a916bd_1.jpg
Emerald Organic Products Restructures Joint Venture Agreement With Todos Medical by Entering Joint Collaboration Agreement
May 08, 2020 10:13 ET | Todos Medical Ltd.
Partnership allows both companies to focus on their core strengths HOLBROOK, NY, REHOVOT, ISRAEL, SINGAPORE AND NEW YORK, NY, May 08, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Emerald Organic...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Appoints Dr. Lauren Chung to its Board of Directors
April 17, 2020 07:30 ET | Todos Medical Ltd.
 Receives valuation of Alzheimer’s disease blood diagnostic LymPro Test Retains Donohoe Advisors to assist with Nasdaq CM™ listing process REHOVOT, Israel, SINGAPORE and NEW YORK, NY, April 17, 2020...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Provides Corporate Update
April 09, 2020 09:03 ET | Todos Medical Ltd.
 Corona Diagnostics JV adds COVID-19 EUA-submitted point-of-care antibody test kit suppliers Ongoing pre-commercial clinical trial for TMB-1 and TMB-2 progressing despite COVID-19 Full acquisition of...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Expands on Coronavirus (COVID-19) Distribution Agreement with Shanghai Liangrun Subsidiary Gibraltar
March 30, 2020 09:42 ET | Todos Medical Ltd.
 Todos expands rights to include Asian countries and to include PCR test kits Corona Diagnostics JV with Emerald Organic responsible for commercialization Dr. Joseph Wee, CEO of Todos Singapore,...
Alliance Funding Group Extends a $20 Million Sales Finance Line to Emerald Organic for Commercialization of its Proprietary, HIPAA Compliant Facial Recognition-enabled Vending Machines
March 05, 2020 09:34 ET | Emerald Organic Products Inc.
 $20M in sales finance secured from Alliance Funding Group to support initial equipment roll-out  Technology allows for the dispensing of a vast array of wellness products, including...
Emerald Organic Reaches Definitive Agreement for a $5 Million Injection of Private Equity Capital
March 03, 2020 10:22 ET | Emerald Organic Products Inc.
Funds will be used to fuel DTC growth and establish national retail presencePreferred Stock has fixed conversion price into common shares of $1.60 New York, NY, March 03, 2020 (GLOBE NEWSWIRE) --...
1547522887207_5c33aa745c253600048c1b5f_logo.jpg
Amarantus Acquires Majority Interest in CBD Wellness Company Hempori
January 30, 2020 09:05 ET | Amarantus Bioscience Holdings, Inc.
 Strong customer retention at both stores in Dallas, TX with growing online presence Focus  on delivering wellness solutions by engaging customers to participate in clinical studies and provide...
1547522887207_5c33aa745c253600048c1b5f_logo.jpg
Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products
January 02, 2020 08:14 ET | Amarantus Bioscience Holdings, Inc.
 Emerald gains exclusive worldwide development rights to ESS, MANF and PhenoGuard Amarantus receives Emerald preferred stock valued at a minimum of $66.6 million New York, NY, Jan. 02,...
1547522887207_5c33aa745c253600048c1b5f_logo.jpg
Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic Products
October 24, 2019 09:34 ET | Amarantus Bioscience Holdings, Inc.
 Amarantus is receiving Emerald Preferred Stock with a minimum value of $100M in 2022 Treatment candidates are for Alzheimer’s, ADHD, Parkinson’s, severe burns and vision loss Portfolio includes...